棕榈酸帕利哌酮注射液治疗精神分裂症的临床效果  

Clinical effect of paliperidone palmitate injection in the treatment of schizophrenia

作　　者：程鹏 CHENG Peng(Department of Tertiary Therapy,Tiexi District Mental Health Center,Shenyang 110000,China)

机构地区：[1]辽宁省沈阳市铁西区精神卫生中心三疗科,110000

出　　处：《中国现代药物应用》2022年第16期165-167,共3页Chinese Journal of Modern Drug Application

摘　　要：目的研究棕榈酸帕利哌酮注射液治疗精神分裂症的临床效果。方法72例精神分裂症患者,随机分为观察组与对照组,各36例。观察组患者采用棕榈酸帕利哌酮注射液进行治疗,对照组采用注射用利培酮微球进行治疗。比较两组患者的临床疗效。结果观察组总有效率94.44%明显高于对照组的69.44%,差异有统计学意义(P<0.05)。结论精神分裂症患者通过棕榈酸帕利哌酮注射液治疗,可有效提升整体疗效,改善患者的相关症状,值得推广。Objective To study the clinical effect of paliperidone palmitate injection in the treatment of schizophrenia.Methods A total of 72 patients with schizophrenia were randomly divided into observation group and control group,with 36 cases in each group.The observation group was treated with paliperidone palmitate injection,and the control group was treated with risperidone for depot suspension.The clinical efficacy of the two groups was compared.Results The total effective rate 94.44%of the observation group was significantly higher than 69.44%of the control group,and the difference was statistically significant(P<0.05).Conclusion Paliperidone palmitate injection can effectively improve the overall efficacy and improve the related symptoms of patients with schizophrenia,which is worthy of promotion.

关 键 词：棕榈酸帕利哌酮注射液 精神分裂症 注射用利培酮微球 

分 类 号：R749.3[医药卫生—神经病学与精神病学]